image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Chemring - Eps of 193p forecast for 2009

August 2008

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CHG
  • Price:
  • 2360p
News of another acquisition alongside Chemring's interim results was enough to lead brokers to make yet another round of upgrades to forecasts. Results themselves were quite good with pretax profit rising 17% to £23.6m on turnover that rose 41% to £150m. Eps was up 24% to 52p. Net debt increased from just under £100m to £141m reflecting acquisitions. Encouragingly the order book rose 45% to a record £425m. Chemring's countermeasures business, which supplies decoys such as flares and chaff to prevent enemy missiles hitting military targets, grew turnover by 21% to £71m with profit increasing 7% to £19m. This lag reflected a changing mix caused by a significant increase in sales of lower margin naval rounds but this should re ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X